AVITA Medical, Inc. 8-K

What Happened
AVITA Medical, Inc. (RCEL) held its 2026 Annual Meeting of Stockholders by webcast on June 3, 2026 (June 4, 2026 in Australia). At the record date of April 9, 2026 there were 30,776,689 shares outstanding. A total of 15,592,447 shares were voted at the meeting, constituting a quorum. Stockholders approved grants of stock options and restricted stock units to the company’s non‑executive directors in the form of annual and initial grants, as described in the company’s definitive proxy statement filed April 22, 2026 (Proposals 4–7, 9 and 11).

Key Details

• Record date: April 9, 2026; outstanding common shares: 30,776,689.
• Shares voted at meeting: 15,592,447 (quorum achieved).
• Action approved: annual and initial equity awards (options and RSUs) for non‑executive directors; details referenced in the Schedule 14A proxy filed April 22, 2026 and summarized in the 8‑K.
• Meeting format: held solely by remote communication via live webcast on June 3, 2026.

Why It Matters
Stockholder approval of director equity awards enables the company to grant options and restricted stock units to board members, which can affect future share dilution and director compensation expense. The meeting results (quorum and vote totals) confirm the approvals are valid under corporate governance rules. Investors tracking share count, potential dilution, or board compensation should review the proxy and the 8‑K paragraphs referenced for the specific grant sizes and vesting terms.